New phase 3 analyses show centanafadine improves adult ADHD executive function and emotional regulation beyond core symptoms, as FDA review advances toward July 2026.
Lenard A. Adler, MD
Advertisement
Dr Adler is the director of the adult ADHD program at NYU Langone Health.
Articles by Lenard A. Adler, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder
2
Celebrating the First APA Panel of Transgender Psychiatrists of Color: A Conversation With Emrys Fonseca, MD, MS
3
Preventing Relapse in Schizophrenia: Focus on Women’s Mental Health
4
Seltorexant as Adjunctive Therapy for MDD With Insomnia
5